cardiovascular (heart) disease

Vanderbilt's Kathryn Lindley, MD, has worked with the American College of Obstetricians and Gynecologists and the Centers for Disease Control and Prevention to develop a national toolkit for non-obstetricians to better identify and treat pregnant and postpartum patients with cardiovascular emergencies.

In a novel procedure, the Vanderbilt Heart & Vascular Institute (VHVI) successfully performed the first large-flange Innovalve transcatheter mitral valve replacement.

Vanderbilt University Medical Center has received a federal grant to establish a first-of-its-kind training program in patient-oriented and health systems research focused on acute heart, lung, blood and sleep disorders in the hospital setting.

Study seeks to better understand the mechanism behind the association between preeclampsia and other hypertensive disorders of pregnancy and cardiovascular disease.

New implantable device helps heart failure patients monitor crucial health indicators remotely, reducing the need for hospital visits.

Vanderbilt research finds that GLP1 receptor agonists — a class of diabetes medications — are associated with fewer major adverse cardiovascular events than another type of diabetes drug (DPP4 inhibitors) in older veterans with no prior heart disease.

A Vanderbilt study found that automated targeted reminders for clinicians helped increase prescribing of high intensity statins for patients with various atherosclerotic cardiovascular disease diagnoses, including coronary or peripheral artery disease and ischemic stroke.